Cancer: another casualty of geopolitical unrest? The Lancet Oncology ++ ++...

Aumolertinib as adjuvant therapy in resected EGFR-mutated non-small-cell lung cancer (ARTS): a double-blind, multicentre, randomised, controlled, phase 3 trial Liang Zhang, MDa ∙ Xiqin Zhang, BSb ∙ Lin Wu, MDc ∙ Wenqun Xing, BSd ∙ Chunling Liu, MSe ∙ Prof Peng Zhang, MDf ∙ et al. https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(25)00643-6/abstract?dgcid=raven_jbs_etoc_feature_lanonc Expert recommendations for the conduct and appraisal of qualitative research in oncology Erica C Kaye, MDa,* erica.kaye@stjude.org ∙ Jori Bogetz, MDd,e,* ∙ Krysta S Barton, PhDf ∙ Cynthia J Bell, PhDg ∙ Emily E Johnston, MDh,i ∙ Rachel A Pozzar, PhDj ∙ et al. https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(25)00670-9/abstract?dgcid=raven_jbs_etoc_feature_lanonc Cancer: another casualty of geopolitical unrest? The Lancet Oncology https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(26)00021-5/fulltext?dgcid=raven_jbs_etoc_email Feb 2026 Volume 27Number 2p137-268, e56-e122 https://www.thelancet.com/journals/lanonc/issue/vol27no2/PIIS1470-2045(26)X2001-0